Jonathan P. Mow - Nov 19, 2021 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc (PHASQ)

Role
Chief Executive Officer, Director
Signature
/s/ John P. Sharp, Attorney-in-fact
Stock symbol
PHASQ
Transactions as of
Nov 19, 2021
Transactions value $
$11,302
Form type
4
Date filed
11/23/2021, 05:55 PM
Previous filing
Nov 3, 2021
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHASQ Common Stock Award $11.3K +5.62K +3.37% $2.01* 172K Nov 19, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).